Walleye Trading LLC Vaxcyte, Inc. Put Options Transaction History

Walleye Trading LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$60.06 - $78.77 $150,150 - $196,925	-2,500 Reduced 45.45%	3,000 $226,000
Q1 2024 May 15, 2024	BUY	$59.79 - $81.05 $328,845 - $445,775	5,500 New	5,500 $375,000
Q2 2023 Aug 14, 2023	BUY	$34.66 - $54.07 $17,330 - $27,035	500 New	500 $24,000
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $255,191 - $594,580	12,400 New	12,400 $594,000

352

122M

775K

433K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.25B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.